| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $-0.0B | $-0.0B | $-0.0B | $-0.0B | $-0.0B | $-0.0B | $-0.0B | $-0.0B |
| Net Income | $-0.0B | $0.0B | $0.0B | $0.0B | $-0.0B | $-0.0B | $0.0B | $0.0B |
| EPS (Basic) | $-0.16 | $0.02 | $0.06 | $0.03 | — | — | $1.20 | $0.71 |
| EPS (Diluted) | $-0.16 | $0.02 | — | — | — | $0.89 | $0.89 | $0.52 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Current Assets | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Cash & Equivalents | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Total Liabilities | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Current Liabilities | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Stockholders' Equity | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-0.0B | $0.0B | $0.0B | $0.0B | $-0.0B | $-0.0B | $-0.0B | $-0.0B |
| Investing Cash Flow | $-0.0B | $-0.0B | $-0.0B | $-0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $0.0B | $-0.0B | $0.0B | $-0.0B | $0.0B | $0.0B | $-0.0B | $0.0B |